241 related articles for article (PubMed ID: 8657488)
1. [Fever in children with hematologic neoplastic diseases and implanted Broviac-Hickman catheters].
Pilecki O; Wysocki M; Swiatkiewicz V; Kołtan A; Kołtan S; Kurylak A; Kurylak D
Pediatr Pol; 1995 Mar; 70(3):213-8. PubMed ID: 8657488
[TBL] [Abstract][Full Text] [Related]
2. [Infectious and non-infectious complications of tunneled central catheters in hematologic patients].
Albo López C; López Rodríguez D; Constenla Camba MI; Jimenéz Blanco A; Araujo LF; García-Medina J
Sangre (Barc); 1999 Jun; 44(3):176-81. PubMed ID: 10481577
[TBL] [Abstract][Full Text] [Related]
3. Skin and soft tissue complications in pediatric leukemia patients with and without central venous catheters.
Demircioğlu F; Ylmaz S; Oren H; Ozgüven AA; Irken G
J Pediatr Hematol Oncol; 2008 Jan; 30(1):32-5. PubMed ID: 18176177
[TBL] [Abstract][Full Text] [Related]
4. [Sepsis in children with malignant neoplasia, equipped with a Broviac-type venous catheter].
Garaventa A; Castagnola E; Dallorso S; Dini G; Trucco D; Vianello O; Carrega G; Cuneo P; Buffa P; Magillo P
Pediatr Med Chir; 1995; 17(2):147-50. PubMed ID: 7610079
[TBL] [Abstract][Full Text] [Related]
5. Complications of Hickman-Broviac catheters in children with malignancies.
Perdikaris P; Petsios K; Vasilatou-Kosmidis H; Matziou V
Pediatr Hematol Oncol; 2008 Jun; 25(5):375-84. PubMed ID: 18569839
[TBL] [Abstract][Full Text] [Related]
6. [Central venous catheters with subcutaneous ports for long-term chemotherapy in pediatric oncology].
Zmudzka-Stapińska I; Rawicz M; Sopyło B; Jaranowska D; Rokicka-Milewska R
Acta Haematol Pol; 1992; 23(3):171-8. PubMed ID: 1492541
[TBL] [Abstract][Full Text] [Related]
7. Empiric treatment with once-daily cefonicid and gentamicin for febrile non-neutropenic pediatric cancer patients with indwelling central venous catheters.
Averbuch D; Makhoul R; Rotshild V; Weintraub M; Engelhard D
J Pediatr Hematol Oncol; 2008 Jul; 30(7):527-32. PubMed ID: 18797200
[TBL] [Abstract][Full Text] [Related]
8. [Central venous access: our experience with Hickman and Broviac catheter in children].
Milanović D; Krstić Z; Vukadinović V
Srp Arh Celok Lek; 1994; 122(5-6):189-91. PubMed ID: 17977427
[TBL] [Abstract][Full Text] [Related]
9. Prolonged venous access in cancer patients.
Guenier C; Ferreira J; Pector JC
Eur J Surg Oncol; 1989 Dec; 15(6):553-5. PubMed ID: 2599125
[TBL] [Abstract][Full Text] [Related]
10. Complications of implanted central venous catheters in neutropenic children.
Elihu A; Gollin G
Am Surg; 2007 Oct; 73(10):1079-82. PubMed ID: 17983086
[TBL] [Abstract][Full Text] [Related]
11. Incidence of catheter-related infections within 30 days from insertion of Hickman-Broviac catheters.
Castagnola E; Molinari AC; Giacchino M; Chiapello N; Moroni C; Caviglia I; Fratino G; Haupt R
Pediatr Blood Cancer; 2007 Jan; 48(1):35-8. PubMed ID: 16358302
[TBL] [Abstract][Full Text] [Related]
12. [Hickman catheters for chemotherapy in patients with acute myeloblastic leukemia].
Hvid K; Rosenborg D
Ugeskr Laeger; 2005 Nov; 167(48):4566-9. PubMed ID: 16324439
[TBL] [Abstract][Full Text] [Related]
13. Experience with minimal complications in implanted catheters in children.
Hockenberry MJ; Schultz WH; Bennett B; Bryant R; Falletta JM
Am J Pediatr Hematol Oncol; 1989; 11(3):295-9. PubMed ID: 2782556
[TBL] [Abstract][Full Text] [Related]
14. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
[TBL] [Abstract][Full Text] [Related]
15. [Advantages and disadvantages in the use of central venous catheters in children with malignant diseases].
Sporisević L; Hasanbegović E; Hadzihasanović E; Bajraktarević A; Khatib H; Hamamdzić M
Med Arh; 1999; 53(3 Suppl 2):19-22. PubMed ID: 10758755
[TBL] [Abstract][Full Text] [Related]
16. Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies.
Chee L; Brown M; Sasadeusz J; MacGregor L; Grigg AP
J Infect; 2008 Apr; 56(4):227-33. PubMed ID: 18342947
[TBL] [Abstract][Full Text] [Related]
17. Question 3. Do Portacaths or Hickman lines have a higher risk of catheter-related bloodstream infections in children with leukaemia?
Alexander N
Arch Dis Child; 2010 Mar; 95(3):239-41. PubMed ID: 20308343
[No Abstract] [Full Text] [Related]
18. Management of indwelling central venous catheters in pediatric cancer patients with fever and neutropenia.
Riikonen P; Saarinen UM; Lähteenoja KM; Jalanko H
Scand J Infect Dis; 1993; 25(3):357-64. PubMed ID: 8362233
[TBL] [Abstract][Full Text] [Related]
19. How long does it take to "rule out" bacteremia in children with central venous catheters?
Shah SS; Downes KJ; Elliott MR; Bell LM; McGowan KL; Metlay JP
Pediatrics; 2008 Jan; 121(1):135-41. PubMed ID: 18166567
[TBL] [Abstract][Full Text] [Related]
20. Role of Broviac catheters in infections in children with cancer.
Viscoli C; Garaventa A; Boni L; Melodia A; Dini G; Cuneo R; Rizzo A; Moroni C; Rogers D; De Bernardi B
Pediatr Infect Dis J; 1988 Aug; 7(8):556-60. PubMed ID: 3174299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
